These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. TCF7L1 regulates cytokine response and neuroendocrine differentiation of prostate cancer. Wen YC; Liu YN; Yeh HL; Chen WH; Jiang KC; Lin SR; Huang J; Hsiao M; Chen WY Oncogenesis; 2021 Nov; 10(11):81. PubMed ID: 34799554 [TBL] [Abstract][Full Text] [Related]
33. Neuroendocrine Differentiation of Prostate Cancer-An Intriguing Example of Tumor Evolution at Play. Patel GK; Chugh N; Tripathi M Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31547070 [TBL] [Abstract][Full Text] [Related]
34. ADT with antiandrogens in prostate cancer induces adverse effect of increasing resistance, neuroendocrine differentiation and tumor metastasis. Niu Y; Guo C; Wen S; Tian J; Luo J; Wang K; Tian H; Yeh S; Chang C Cancer Lett; 2018 Dec; 439():47-55. PubMed ID: 30227222 [TBL] [Abstract][Full Text] [Related]
35. Targeting Wnt/EZH2/microRNA-708 signaling pathway inhibits neuroendocrine differentiation in prostate cancer. Shan J; Al-Muftah MA; Al-Kowari MK; Abuaqel SWJ; Al-Rumaihi K; Al-Bozom I; Li P; Chouchane L Cell Death Discov; 2019; 5():139. PubMed ID: 31583122 [TBL] [Abstract][Full Text] [Related]
36. Blocking the Feedback Loop between Neuroendocrine Differentiation and Macrophages Improves the Therapeutic Effects of Enzalutamide (MDV3100) on Prostate Cancer. Wang C; Peng G; Huang H; Liu F; Kong DP; Dong KQ; Dai LH; Zhou Z; Wang KJ; Yang J; Cheng YQ; Gao X; Qu M; Wang HR; Zhu F; Tian QQ; Liu D; Cao L; Cui XG; Xu CL; Xu DF; Sun YH Clin Cancer Res; 2018 Feb; 24(3):708-723. PubMed ID: 29191973 [No Abstract] [Full Text] [Related]
37. The Neuropilin-1/PKC axis promotes neuroendocrine differentiation and drug resistance of prostate cancer. Blanc C; Moktefi A; Jolly A; de la Grange P; Gay D; Nicolaiew N; Semprez F; Maillé P; Soyeux P; Firlej V; Vacherot F; Destouches D; Amiche M; Terry S; de la Taille A; Londoño-Vallejo A; Allory Y; Delbé J; Hamma-Kourbali Y Br J Cancer; 2023 Mar; 128(5):918-927. PubMed ID: 36550208 [TBL] [Abstract][Full Text] [Related]
39. Downregulation of lysine-specific demethylase 1 enhances the sensitivity of hormone-sensitive prostate cancer cells to androgen deprivation therapy. Wang M; Liu X; Chen Z; Zhang L; Weng X Oncol Lett; 2021 Feb; 21(2):93. PubMed ID: 33376526 [TBL] [Abstract][Full Text] [Related]
40. Crosstalk Between AR and Wnt Signaling Promotes Castration-Resistant Prostate Cancer Growth. Luo J; Wang D; Wan X; Xu Y; Lu Y; Kong Z; Li D; Gu W; Wang C; Li Y; Ji C; Gu S; Xu Y Onco Targets Ther; 2020; 13():9257-9267. PubMed ID: 32982312 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]